logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Epilepsy

    Medications for Epilepsy

    FiltersReset Filters
    31 results

    • carbamazepine

      (Carbamazepine)
      Jubilant Cadista Pharmaceuticals Inc.
      Usage: Carbamazepine is indicated as an anticonvulsant for partial seizures (especially complex symptomatology), generalized tonic-clonic seizures, and mixed seizure patterns. It is also used to treat pain from true trigeminal neuralgia and has reported benefits in glossopharyngeal neuralgia. Not for trivial pain relief.

    • carbamazepine

      (Carbamazepine)
      UMEDICA LABORATORIES PRIVATE LIMITED
      Usage: Carbamazepine is indicated as an anticonvulsant for treating partial seizures with complex symptomatology, generalized tonic-clonic seizures, and mixed seizure patterns. It is also used to alleviate pain from true trigeminal neuralgia and has shown benefits in glossopharyngeal neuralgia, but is not for general pain relief.

    • carbamazepine

      (carbamazepine)
      Zydus Lifesciences Limited
      Usage: Carbamazepine extended-release tablets are indicated for the treatment of epilepsy, specifically for partial seizures (complex symptomatology), generalized tonic-clonic seizures, and mixed seizure patterns. They are also used to manage pain associated with trigeminal neuralgia and potentially glossopharyngeal neuralgia, but not for trivial aches.

    • diazepam

      (Diazepam)
      Lupin Pharmaceuticals,Inc.
      Usage: Diazepam rectal gel is indicated for the acute treatment of intermittent seizure clusters or repetitive seizures in patients with epilepsy aged 2 years and older, differentiating these episodes from the patient's typical seizure pattern.

    • divalproex sodium

      (Divalproex sodium)
      NorthStar RxLLC
      Usage: Divalproex sodium extended-release tablets are indicated for treating acute manic or mixed episodes of bipolar disorder, complex partial seizures, simple and complex absence seizures, and for migraine prophylaxis. Long-term effectiveness in mania is unproven, and the drug is contraindicated in pregnant women due to potential fetal risks.

    • divalproex sodium

      (Divalproex Sodium)
      Unichem Pharmaceuticals (USA), Inc.
      Usage: Divalproex sodium delayed-release tablets are indicated for the treatment of manic episodes in bipolar disorder, complex partial seizures, simple and complex absence seizures, and for migraine prophylaxis. Its use in pregnant women or women planning pregnancy is restricted due to potential fetal risks.

    • fludeoxyglucose

      (Fludeoxyglucose F18)
      MIPS Cyclotron & Radiochemistry Facility
      Usage: Fludeoxyglucose F18 Injection is indicated for PET imaging in oncology to assess glucose metabolism in malignancies, in cardiology for evaluating left ventricular function in coronary artery disease, and in neurology to identify abnormal glucose metabolism related to epileptic seizures.

    • fludeoxyglucose f 18

      (Fludeoxyglucose F-18)
      Mayo Clinic
      Usage: Fludeoxyglucose F 18 Injection USP is indicated for PET imaging to assess abnormal glucose metabolism in oncology for malignancy evaluation, in cardiology for identifying reversible left ventricular dysfunction in coronary artery disease, and in neurology to locate abnormal glucose metabolism related to epileptic seizures.

    • fludeoxyglucose f 18

      (FLUDEOXYGLUCOSE F-18)
      UIHC-P E T IMAGING CENTER
      Usage: This drug is indicated for identifying regions of abnormal glucose metabolism linked to epileptic seizure foci in neurology.

    • fludeoxyglucose f 18

      (Fludeoxyglucose F 18)
      The University of Utah DBA Cyclotron Radiochemistry Lab / Huntsman Cancer Institute
      Usage: Fludeoxyglucose F-18 Injection, USP is indicated for positron emission tomography (PET) imaging in oncology for cancer evaluation, cardiology to assess myocardial function in coronary artery disease, and neurology to identify abnormal glucose metabolism related to epileptic seizures.